FI70027C - Foerfarande foer framstaellning av terapeutiskt anvaendbara 1819-dinorpregn-4-en-3,20-dioner - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara 1819-dinorpregn-4-en-3,20-dioner Download PDF

Info

Publication number
FI70027C
FI70027C FI793847A FI793847A FI70027C FI 70027 C FI70027 C FI 70027C FI 793847 A FI793847 A FI 793847A FI 793847 A FI793847 A FI 793847A FI 70027 C FI70027 C FI 70027C
Authority
FI
Finland
Prior art keywords
formula
compound
mixture
agent
isomer
Prior art date
Application number
FI793847A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI793847A (fi
FI70027B (fi
Inventor
Lucien Nedelec
Vesperto Torelli
Robert Fournex
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of FI793847A publication Critical patent/FI793847A/fi
Application granted granted Critical
Publication of FI70027B publication Critical patent/FI70027B/fi
Publication of FI70027C publication Critical patent/FI70027C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/0065—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified
    • C07J7/007—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by an OH group free esterified or etherified not substituted in position 17 alfa

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
FI793847A 1978-12-13 1979-12-10 Foerfarande foer framstaellning av terapeutiskt anvaendbara 1819-dinorpregn-4-en-3,20-dioner FI70027C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7835046 1978-12-13
FR7835046A FR2444047A1 (fr) 1978-12-13 1978-12-13 Nouveaux derives 2,2-dimethyl 19-nor steroides, leur procede de preparation et leur application comme medicaments

Publications (3)

Publication Number Publication Date
FI793847A FI793847A (fi) 1980-06-14
FI70027B FI70027B (fi) 1986-01-31
FI70027C true FI70027C (fi) 1986-09-12

Family

ID=9216044

Family Applications (1)

Application Number Title Priority Date Filing Date
FI793847A FI70027C (fi) 1978-12-13 1979-12-10 Foerfarande foer framstaellning av terapeutiskt anvaendbara 1819-dinorpregn-4-en-3,20-dioner

Country Status (14)

Country Link
US (1) US4263290A (nl)
EP (2) EP0012641B1 (nl)
JP (1) JPS5585598A (nl)
AU (1) AU527582B2 (nl)
CA (1) CA1146531A (nl)
DK (1) DK527379A (nl)
ES (1) ES8102149A1 (nl)
FI (1) FI70027C (nl)
FR (1) FR2444047A1 (nl)
HU (1) HU180931B (nl)
IE (1) IE49235B1 (nl)
PT (1) PT70575A (nl)
SU (1) SU1178325A3 (nl)
ZA (1) ZA796194B (nl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3229993A (en) * 1992-11-30 1994-06-22 Mallinckrodt Medical, Inc. Steroid-21-phosphate complex of technetium-99m
US20030083231A1 (en) * 1998-11-24 2003-05-01 Ahlem Clarence N. Blood cell deficiency treatment method
FR2917975B1 (fr) * 2007-06-26 2009-10-16 Ceva Sante Animale Sa Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains
US20090270356A1 (en) * 2008-04-28 2009-10-29 Ceva Sante Animale Sa Compositions and treatments of heart failure in non-human mammal animals
CA2813433C (en) 2010-10-27 2019-08-20 Dignity Health Trimegestone (tmg) for treatment of preterm birth

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138460A (en) * 1965-06-01 1969-01-01 Merck & Co Inc Steroid compounds
FR1476572A (fr) * 1965-09-13 1967-04-14 Gonènes synthétiques et leur procédé de préparation
FR2322606A1 (fr) * 1975-09-02 1977-04-01 Roussel Uclaf Nouveaux 2,2-dimethyl steroides, leur procede de preparation et leur application comme medicament
FR2364655A1 (fr) * 1976-09-17 1978-04-14 Roussel Uclaf Nouveaux 2,2-dimethyl 19-nor steroides, leur procede de preparation et leur application comme medicament

Also Published As

Publication number Publication date
FR2444047B1 (nl) 1982-05-28
US4263290A (en) 1981-04-21
DK527379A (da) 1980-06-14
AU527582B2 (en) 1983-03-10
IE49235B1 (en) 1985-09-04
IE792420L (en) 1980-06-13
ES486791A0 (es) 1980-12-16
FI793847A (fi) 1980-06-14
EP0044575B1 (fr) 1984-03-21
JPS6337796B2 (nl) 1988-07-27
HU180931B (en) 1983-05-30
CA1146531A (fr) 1983-05-17
FI70027B (fi) 1986-01-31
ES8102149A1 (es) 1980-12-16
EP0012641B1 (fr) 1982-05-12
EP0012641A2 (fr) 1980-06-25
SU1178325A3 (ru) 1985-09-07
PT70575A (fr) 1980-01-01
AU5376279A (en) 1980-07-10
EP0012641A3 (en) 1980-09-17
FR2444047A1 (fr) 1980-07-11
EP0044575A1 (fr) 1982-01-27
ZA796194B (en) 1980-11-26
JPS5585598A (en) 1980-06-27

Similar Documents

Publication Publication Date Title
CELLA et al. Steroidal aldosterone blockers. II1
NO169188B (no) Kombinert sluseroerventil og stengeventil
US4337263A (en) 1-Aryl-4-γ-arylsulphonyl-3-aminopropoxy-1H-pyrazoles and their use as hypolipemiant and hypocholesterolemiant agents
CH637409A5 (fr) Steroides, leur preparation et composition therapeutique les contenant.
DK165595B (da) 17-androstancarboxylsyreestere, fremgangsmaade til fremstilling heraf og farmaceutisk praeparat indeholdende samme samt anvendelse af samme til fremstilling af et medikament til behandling af svigtende hjertefunktion
CA2090584C (fr) Steroides comportant en position 17 un radical methylene lactone, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FI70027C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 1819-dinorpregn-4-en-3,20-dioner
JPS59139400A (ja) 抗アルドステロン活性ステロイド誘導体
EP0898579B1 (fr) Derives de pregnane sans substituent en position 17-alpha-, leur application a titre de medicament, leur procede de preparation, les intermediaires de ce procede et les compositions les contenant
EP0412907B1 (fr) Nouveaux esters d'acides organiques avec des alcools dérivés de 19-nor stéroides et leurs sels, leur procédé de préparation et les intermédiaires de ce procédé, leur application à titre de médicaments et les compositions les renfermant
US4684636A (en) Antiandrogenic sulfonylsteroidopyrazoles and processes for preparation method of use and compositions thereof
NO791142L (no) Corticosteroid antiinflammatoriske midler
US4331663A (en) 4α,5α-Epoxy-3,20-dioxopregnane-2α,16α-dicarbonitrile and intermediates and process for preparation, method of use and compositions thereof
FR2658516A1 (fr) Nouveaux produits sterouides comportant un radical spiro en position 17, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
US4096253A (en) 1-Oxygenated steroids
IL28867A (en) 1-adamantyl and 1-adamantylmethyl carbonates of testosterone and derivatives thereof
FR2489335A1 (nl)
DK167574B1 (da) Fremgangsmaade til fremstilling af en 16,17-acetalsubstitueret androstan-17beta-(2-oxoethylenoxy)-forbindelse
JPS6239160B2 (nl)
EP0002401B1 (fr) Dérivés de naphtalène, leur préparation et leur application en thérapeutique
FI84820C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara n-bicykloheptyl- och n -bicykloheptenylimidazoler.
CA1072540A (fr) Procede de preparation de nouveaux 2,2-dimethyl steroides
JPH0133115B2 (nl)
JPS6229438B2 (nl)
EP0338065A1 (fr) Derives de la 19-nor progesterone, leur preparation et leur utilisation

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: ROUSSEL UCLAF SOCIETE ANONYME